Genomic and Clinical Impact of Smoking on Therapeutic Outcomes in Prostate Cancer: A Public Databases Analysis
Smoking history was significantly associated with aggressive clinicopathological features and a poor prognosis in patients with PCa. Our findings suggest that smokers with PCa may receive greater benefit from the early administration of taxane chemotherapy in comparison to other treatment regimens.
Authors
- Keisuke Goto (ORCID: https://orcid.org/0000-0002-4165-1809)
- Kenshiro Takemoto (ORCID: https://orcid.org/0000-0002-9077-4733)
- Miki Naito (ORCID: https://orcid.org/0000-0003-3485-0751)
- Yuki Kohada (ORCID: https://orcid.org/0000-0002-6510-7461)
- Yoshinori Nakano
- Keisuke Hieda (ORCID: https://orcid.org/0000-0001-5182-8666)
- Kazuma Yukihiro
- Nobuyuki Hinata
- Shinsaku Tasaka
- Naofumi Nomura
- Go Kobayashi
- Tomoya Hatayama
- Akihiro Goriki
- Hiroyuki Kitano
- Yohei Sekino
- Shunsuke Miyamoto
- Kohei Kobatake
Institutions
- Hiroshima University (JP)
- Radiation Effects Research Foundation (JP)
Publication Details
- Journal
- The Prostate
- Published
- 2026-01-26
- DOI
- https://doi.org/10.1002/pros.70134
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00